© Reuters. FILE PHOTO: People pose with syringe with needle in front of displayed AstraZeneca logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration
(Changes headline after company clarifies it did not withdraw its U.S. application for COVID vaccine, but decided not to file the application altogether)
LONDON (Reuters) – AstraZeneca (NASDAQ:) is no longer pursuing U.S. approval of its COVID-19 vaccine, Chief Executive Pascal Soriot said in a media call on Thursday.
Demand for vaccines in the country is declining and the market is well served by the mRNA shots, he said.
(This story has been officially corrected to change headline after company clarifies it did not withdraw its U.S. application for COVID vaccine, but decided not to file the application altogether)
